Denali Therapeutics
DNLI
DNLI
213 hedge funds and large institutions have $4.28B invested in Denali Therapeutics in 2021 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 81 increasing their positions, 65 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
3.2% more ownership
Funds ownership: 66.54% → 69.74% (+3.2%)
1% more funds holding
Funds holding: 210 → 213 (+3)
32% less capital invested
Capital invested by funds: $6.31B → $4.28B (-$2.03B)
Holders
213
Holding in Top 10
5
Calls
$12.4M
Puts
$5.19M
Top Buyers
| 1 | +$51.1M | |
| 2 | +$48.4M | |
| 3 | +$26.5M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$26.5M |
| 5 |
State Street
Boston,
Massachusetts
|
+$24.1M |
Top Sellers
| 1 | -$25.4M | |
| 2 | -$21.7M | |
| 3 | -$18.3M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$16.9M |
| 5 |
LCG
Lisanti Capital Growth
New York
|
-$7.7M |